This indicator maps the biomedical and health R&I funding commited under H2020 and FP7, including breakdowns by discipline. This provides useful background information on the scale and nature of funding which sets the context for the different types of societal impact tracked. Source: Cordis
| Year | FP7 | H2020 |
|---|---|---|
| 2007 | 1,645,000.0 | - |
| 2008 | 1,007,904,589.0 | - |
| 2009 | 856,349,405.4 | - |
| 2010 | 984,061,388.7 | - |
| 2011 | 1,184,343,848.0 | - |
| 2012 | 1,416,375,667.0 | - |
| 2013 | 1,364,614,544.0 | - |
| 2014 | 326,230,798.4 | 130,813,208.4 |
| 2015 | 63,076,499.6 | 1,076,227,852.0 |
| 2016 | 7,500.0 | 929,925,928.2 |
| 2017 | - | 719,482,254.5 |
| 2018 | - | 735,067,553.2 |
| 2019 | - | 302,655,859.4 |
| 2020 | - | 596,687,388.6 |
| 2021 | - | 100,013,611.4 |